As evidence accrues, we, and others, will monitor what it means for the impact of GLP-1 medications on SMM, but so far we have not seen any compelling clinical data (although new systematic reviews and meta analyses have been proposed ) that GLP-1 medications lead to pathological skeletal muscle mass loss relative to what has been demonstrated and observed in other weight loss interventions
This release may include links or references for which the issuer may receive compensation, at no additional cost to the reader
From marketing materials and patient education tools to cutting-edge technology, our offerings empower you to attract new clients, enhance patient satisfaction, and drive business growth
Allergy warning: Manufactured in a facility that processes milk, soy, egg proteins, gluten, and peanuts